It’s possible that GLP-1s may be useful for a range of substance use disorders, including opioid use disorder and nicotine ...
2d
GlobalData on MSNHain Celestial positions for longer-term GLP-1 benefit as sales growth evaporatesAs Hain Celestial gears up for a potential disposal of its personal-care business to become a “pure play” food and beverage ...
These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new ...
4d
GlobalData on MSNFlowers Foods eyes GLP-1 effect as bread category weakness hits salesFlowers has documented for several quarters a consumer shift away from traditional loaves toward more “differentiated and ...
It’s obvious these drugs are trimming waistlines across the nation; what may be less obvious is that they might also reshape ...
Hims & Hers hit the bullseye with its Super Bowl ad, sparking a surge in clicks to its site.The ad also hit a nerve with the ...
The spot “is a clear violation” of the FDCA, “which requires that advertising for prescription drugs — including compounded ...
Ryals McMullian noted consumers are moving away from traditional white and wheat bread into organic, keto, gluten-free and ...
Conagra adds an ‘On Track’ badge on packaging for 26 of its Healthy Choice frozen meals that call out GLP-1 ...
2d
MarketBeat on MSNGLP-1 Alternatives: 2 Stocks Benefiting From Weight Loss TrendsThe supply shortage and high costs of GLP-1 weight loss drugs have created an opportunity for compounded GLP-1 treatments to ...
A human-derived, ultra-long-acting GLP-1 injection independently researched and developed by Innogen, a Shanghai-based ...
20hon MSN
Q4 2024 Management View CEO Eric Green highlighted that the company achieved 3.3% organic revenue growth in Q4 2024, marking a return to quarterly growth. Notable drivers included strong performance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results